BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

100 related articles for article (PubMed ID: 22391726)

  • 1. 11C-acetate PET/CT in bladder urothelial carcinoma: intraindividual comparison with 11C-choline.
    Orevi M; Klein M; Mishani E; Chisin R; Freedman N; Gofrit ON
    Clin Nucl Med; 2012 Apr; 37(4):e67-72. PubMed ID: 22391726
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Diagnostic efficacy of [11C]choline positron emission tomography/computed tomography compared with conventional computed tomography in lymph node staging of patients with bladder cancer prior to radical cystectomy.
    Maurer T; Souvatzoglou M; Kübler H; Opercan K; Schmidt S; Herrmann K; Stollfuss J; Weirich G; Haller B; Gschwend JE; Schwaiger M; Krause BJ; Treiber U
    Eur Urol; 2012 May; 61(5):1031-8. PubMed ID: 22196847
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Diagnostic accuracy of (11)C-choline PET/CT in preoperative lymph node staging of bladder cancer: a systematic comparison with contrast-enhanced CT and histologic findings.
    Brunocilla E; Ceci F; Schiavina R; Castellucci P; Maffione AM; Cevenini M; Bianchi L; Borghesi M; Giunchi F; Fiorentino M; Chondrogiannis S; Colletti PM; Rubello D; Fanti S; Martorana G
    Clin Nucl Med; 2014 May; 39(5):e308-12. PubMed ID: 24458183
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Value of 11C-choline PET and contrast-enhanced CT for staging of bladder cancer: correlation with histopathologic findings.
    Picchio M; Treiber U; Beer AJ; Metz S; Bössner P; van Randenborgh H; Paul R; Weirich G; Souvatzoglou M; Hartung R; Schwaiger M; Piert M
    J Nucl Med; 2006 Jun; 47(6):938-44. PubMed ID: 16741302
    [TBL] [Abstract][Full Text] [Related]  

  • 5. 11C-choline PET/CT and bladder cancer: lymph node metastasis assessment with pathological specimens as reference standard.
    Ceci F; Bianchi L; Graziani T; Castellucci P; Pultrone C; Eugenio B; Martorana G; Colletti PM; Rubello D; Fanti S; Schiavina R
    Clin Nucl Med; 2015 Feb; 40(2):e124-8. PubMed ID: 25247272
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [18F]fluoromethylcholine (FCH) positron emission tomography/computed tomography (PET/CT) for lymph node staging of prostate cancer: a prospective study of 210 patients.
    Poulsen MH; Bouchelouche K; Høilund-Carlsen PF; Petersen H; Gerke O; Steffansen SI; Marcussen N; Svolgaard N; Vach W; Geertsen U; Walter S
    BJU Int; 2012 Dec; 110(11):1666-71. PubMed ID: 22520686
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Visualisation of bladder cancer using (11)C-choline PET: first clinical experience.
    de Jong IJ; Pruim J; Elsinga PH; Jongen MM; Mensink HJ; Vaalburg W
    Eur J Nucl Med Mol Imaging; 2002 Oct; 29(10):1283-8. PubMed ID: 12271408
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [11C]Acetate positron emission tomography-computed tomography imaging of prostate cancer lymph-node metastases correlated with histopathological findings after extended lymphadenectomy.
    Schumacher MC; Radecka E; Hellström M; Jacobsson H; Sundin A
    Scand J Urol; 2015 Feb; 49(1):35-42. PubMed ID: 25001948
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Contribution of 11C-choline positron emission tomography/computerized tomography to preoperative staging of advanced transitional cell carcinoma.
    Gofrit ON; Mishani E; Orevi M; Klein M; Freedman N; Pode D; Shapiro A; Katz R; Libson E; Chisin R
    J Urol; 2006 Sep; 176(3):940-4; discussion 944. PubMed ID: 16890661
    [TBL] [Abstract][Full Text] [Related]  

  • 10. 11C-choline PET/CT for restaging of bladder cancer.
    Graziani T; Ceci F; Lopes FL; Chichero J; Castellucci P; Schiavina R; Bianchi L; Chondrogiannis S; Colletti PM; Costa S; Rubello D; Fanti S
    Clin Nucl Med; 2015 Jan; 40(1):e1-5. PubMed ID: 25188643
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Prospective evaluation of 11C-choline positron emission tomography/computed tomography and diffusion-weighted magnetic resonance imaging for the nodal staging of prostate cancer with a high risk of lymph node metastases.
    Budiharto T; Joniau S; Lerut E; Van den Bergh L; Mottaghy F; Deroose CM; Oyen R; Ameye F; Bogaerts K; Haustermans K; Van Poppel H
    Eur Urol; 2011 Jul; 60(1):125-30. PubMed ID: 21292388
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Use of [11C]choline PET-CT as a noninvasive method for detecting pelvic lymph node status from prostate cancer and relationship with choline kinase expression.
    Contractor K; Challapalli A; Barwick T; Winkler M; Hellawell G; Hazell S; Tomasi G; Al-Nahhas A; Mapelli P; Kenny LM; Tadrous P; Coombes RC; Aboagye EO; Mangar S
    Clin Cancer Res; 2011 Dec; 17(24):7673-83. PubMed ID: 22038995
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Comparison of 11C-choline with 18F-FDG in positron emission tomography/computerized tomography for staging urothelial carcinoma: a prospective study.
    Golan S; Sopov V; Baniel J; Groshar D
    J Urol; 2011 Aug; 186(2):436-41. PubMed ID: 21679983
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Imaging prostate cancer with 11C-choline PET/CT.
    Reske SN; Blumstein NM; Neumaier B; Gottfried HW; Finsterbusch F; Kocot D; Möller P; Glatting G; Perner S
    J Nucl Med; 2006 Aug; 47(8):1249-54. PubMed ID: 16883001
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Is there an additional value of ¹¹C-choline PET-CT to T2-weighted MRI images in the localization of intraprostatic tumor nodules?
    Van den Bergh L; Koole M; Isebaert S; Joniau S; Deroose CM; Oyen R; Lerut E; Budiharto T; Mottaghy F; Bormans G; Van Poppel H; Haustermans K
    Int J Radiat Oncol Biol Phys; 2012 Aug; 83(5):1486-92. PubMed ID: 22284686
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Optimization of PET reconstruction algorithm, SUV thresholding algorithm and PET acquisition time in clinical 11C-acetate PET/CT.
    Strandberg S; Hashemi A; Axelsson J; Riklund K
    PLoS One; 2018; 13(12):e0209169. PubMed ID: 30543705
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Final analysis of a prospective trial on functional imaging for nodal staging in patients with prostate cancer at high risk for lymph node involvement.
    Van den Bergh L; Lerut E; Haustermans K; Deroose CM; Oyen R; Isebaert S; Budiharto T; Ameye F; Mottaghy FM; Bogaerts K; Van Poppel H; Joniau S
    Urol Oncol; 2015 Mar; 33(3):109.e23-31. PubMed ID: 25655681
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Diagnostic value of only 18F-fluorodeocyglucose positron emission tomography/computed tomography-positive lymph nodes in head and neck squamous cell carcinoma.
    Lee SH; Huh SH; Jin SM; Rho YS; Yoon DY; Park CH
    Otolaryngol Head Neck Surg; 2012 Oct; 147(4):692-8. PubMed ID: 22535915
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Comparison of (11)C-choline PET/CT and enhanced CT in the evaluation of patients with pulmonary abnormalities and locoregional lymph node involvement in lung cancer.
    Peng Z; Liu Q; Li M; Han M; Yao S; Liu Q
    Clin Lung Cancer; 2012 Jul; 13(4):312-20. PubMed ID: 22182444
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Value of 11C-choline PET/CT for lung cancer diagnosis and the relation between choline metabolism and proliferation of cancer cells.
    Li M; Peng Z; Liu Q; Sun J; Yao S; Liu Q
    Oncol Rep; 2013 Jan; 29(1):205-11. PubMed ID: 23124523
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.